Replimune (REPL) Equity Ratio (2018 - 2025)

Replimune has disclosed Equity Ratio across 8 years of filings, most recently posting 0.63 for Q4 2025.

• Equity Ratio for Q4 2025 came in at 0.63, down 21.02% year-over-year; the trailing twelve-month figure through Dec 2025 was 0.63 (down 21.02% YoY), and the FY2025 annual result was 0.75, down 1.77% from the prior year.
• Equity Ratio came in at 0.63 for Q4 2025 at Replimune, down from 0.68 in the prior quarter.
• In the past five years, Equity Ratio ranged from a high of 0.92 in Q1 2021 to a low of 0.63 in Q4 2025.
• The 5-year median for Equity Ratio is 0.84 (2023), against an average of 0.82.
• Across the five-year window, Equity Ratio gained 17.01% in 2021 and dropped 21.02% in 2025, its largest moves.
• Replimune's Equity Ratio stood at 0.9 in 2021, then fell by 2.68% to 0.88 in 2022, then slipped by 9.85% to 0.79 in 2023, then increased by 1.03% to 0.8 in 2024, then retreated by 21.02% to 0.63 in 2025.
• The last three Equity Ratio figures came in at 0.63 (Q4 2025), 0.68 (Q3 2025), and 0.72 (Q2 2025), per Business Quant data.